Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Bioverse vs FitRx

By GLP-1 ScorecardUpdated

BioverseFactor scores not reassessed.
Site position #317

Lower score

FitRxFactor scores not reassessed.
Site position #300

Higher score

Score comparison

FitRx has the higher recorded score — 62/100 to 61.4/100, but only just.

FitRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FitRx offers brand-name GLP-1s (Ozempic, Wegovy, Zepbound, Mounjaro) with insurance coordination as low as $25/month, plus compounded semaglutide from $151/month without insurance. Bioverse is close behind and may still be the better fit — see the factor split below.

Before you choose

Before comparing the headline prices, the Bioverse review and the FitRx review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, Bioverse vs Maven Clinic and Bodi Envi vs FitRx compare each of them with another graded program, and the list of alternatives to Bioverse ranks the programs closest to Bioverse on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the SkinnyRx review covers one graded close to these two, at 60.5/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueBioverse +5
68
63
Dose & formulationBioverse +12
77
65
Clinical oversightEven
55
55
Labs & monitoringEven
53
53
FulfillmentFitRx +26
62
88
Contract termsFitRx +14
33
47
Bioverse · top barFitRx · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricBioverseFitRx
WeighScore61.4/10062/100
GradeCC
Site position#317#300
Semaglutide$129/mo (starting dose, compounded)$151/mo (quarterly plan, compounded)
Tirzepatide$399/mo (starting dose, compounded)Not disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
Bioverse

Site position #317 · C

Factor scores not reassessed.

FDAWarning letter issued to Bioverse, Inc. dba Bioverse in September 2025. See the FDA warning-letter database.

Strengths

  • Wide formulary — compounded and brand-name semaglutide + tirzepatide plus metformin
  • No membership, cancellation, doctor, or hidden fees
  • Uses US-licensed, FDA-regulated pharmacies

What to consider

  • No visible LegitScript or PCAB accreditation
  • State availability not disclosed beyond 'a provider licensed in your state'
  • Broader longevity platform (NAD+, B12, glutathione, hair, skincare, heart health) rather than GLP-1 focused
  • FDA issued Bioverse, Inc. dba Bioverse a warning letter in September 2025; the letter is public in FDA's warning-letter database
FitRx

Site position #300 · C

Factor scores not reassessed.

FDAWarning letter issued to FitRX, LLC dba FitRx in February 2026. See the FDA warning-letter database.

Strengths

  • Insurance coordination for brand-name GLP-1s — as low as $25/mo
  • All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • LegitScript certified
  • All 50 states + DC coverage
  • Compounded semaglutide from $151/mo quarterly for uninsured patients

What to consider

  • Insurance coordination may not work for all plans
  • Broader platform (birth control, mental health, hair loss, ED, skincare, primary care)
  • Compounded option is semaglutide only — no compounded tirzepatide
  • FDA issued FitRX, LLC dba FitRx a warning letter in February 2026; the letter is public in FDA's warning-letter database

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard